Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 723 results for "sun pharma advanced research"

Sun Pharma Advanced Research hits new high; zooms 200% in 2015
Business Standard

Pharma shares dip on profit bookings

Related to : Sun Pharma Advanced Research Company Ltd,Strides Arcolab Ltd,Natco Pharma Ltd,Ajanta Pharma Ltd Sun Pharma Advanced Research Company Ltd BSE 20 Mar 15 | 03:28 PM 470.70 -69.45 (-12.86%) NSE 20 Mar 15 | 03:20 PM 472.80 ... Smart Investor, 1 week ago
Markets remain flat; pharma shares gain Smart Investor, 6 days ago
[x]  
Rediff.com

Exit Sun Pharma Advanced Research: Kunal Bothra

Kunal Bothra of LKP Securities is of the view that one may exit Sun Pharma Advanced Research Company.
 Money Control1 week ago Sun Pharma Advanced Research Company shares surge 15 per cent; m-cap up by Rs 1,685 crore  Economic Times3 weeks ago SPARC shares surge 15% on US approval for New Drug Application  Hindu Business Line3 weeks ago SPARC shares surge 15%; m-cap up by Rs 1,685 cr  Rediff.com3 weeks ago
[x]  
NDTV Profit

Why SPARC Shares Surged Over 40% in March

Shares of Sun Pharma Advanced Research Company (SPARC), a subsidiary of Sun Pharma Industries, rallied as much as 10 per cent to hit a new high of Rs 598 on Tuesday. Including today's gain, SPARC is up 42 per cent in the month of March. The stock ...
 NDTV Profit3 weeks ago SPARC shares settle with 5 per cent gain; market capitalisation up by Rs 440 crore  Economic Times3 weeks ago SPARC shares settle with 5 pc gain; mcap up by Rs 440-cr  Business Standard3 weeks ago Sun Pharma, SPARC up 9-10%; antiepileptic drug gets FDA nod  Money Control3 weeks ago

SPARC: More sparks to follow?

Investors seem to be betting big on the prospects of Sun Pharma Advanced Research (SPARC) with the stock gaining 33 per cent since March 4 when the company announced the US FDA approval for a drug, which is used in treating seizures. The upsides ...
 Business Standard India3 weeks ago SPARC gains on drug approval  Hindu Business Line3 weeks ago Dilip Shangvi's Sun Pharma and SPARC on a roll  Hindu Business Line3 weeks ago Sensex, Nifty erase half of early gains; Sun Pharma up 6%  Money Control3 weeks ago

India's Sun Pharma research arm gets U.S. FDA nod for epilepsy therapy

Sun Pharma Advanced Research, the research arm of India's top drug firm Sun Pharmaceuticals, said Wednesday it received U.S. Food and Drug Administration approval to market its epilepsy drug, EPILEPSIA (levetiracetam), in the United States. The ...
 Fierce Biotech Research3 weeks ago Market Research Reports, Inc. (www.marketresearchreports.com): India Pharma Outlook 2015: Accelerating growth to the next level: Moving up the value chain beyond Generics, New Report Launched  BusinessWeek4 weeks ago India Pharma Outlook 2015: Accelerating Growth to the Next Level: Moving Up the Value Chain Beyond Generics, New Report Launched  Digital Journal4 weeks ago Global Alcohol Addiction Therapeutics Pipeline Review 2015 - 23 Companies 35 Drug Profiles  Individual.com3 weeks ago
[x]  

Sun Pharma firm value rises by Rs 1,000 crore

Shares of Sun Pharma advanced research company (Sparc) on Thursday settled with gains of 10 per cent, adding Rs 1,014.53 crore to its market capitalisation, after the company received approval from the US health regulator for new drug application. In two ...
 Asian Age3 weeks ago

SPARC stock touches upper circuit limit; M-cap up by over Rs 1,000 cr

In two trading sessions, the company's stock has now jumped 15 per cent. Shares of Sun Pharma Advanced Research Company (SPARC ) on Thursday settled with gains of 10 per cent, adding Rs 1,014.53 crore to its market capitalisation, after the ...
 Business Today India3 weeks ago SPARC shares touch upper circuit; m-cap up by over Rs 1,000 cr  Business Standard3 weeks ago

SPARC's Elepsia XR tablets receives US FDA approval

Sun Pharma Advanced Research Company Ltd. (SPARC), a wholly owned subsidiary of Sun Pharmaceutical Industries, has received the US Food and Drug Administration (FDA) approval for its New Drug Application (NDA) for Elepsia XR (levetiracetam ...
 PharmaBiz3 weeks ago SPARC receives USFDA approval for 'ELEPSIA XR' extended-release tablets  Indian-Commodity3 weeks ago SPARC trades jubilantly on receiving USFDA approval for ELEPSIA XR extended-release tablets  Arihant Capital3 weeks ago SPARC shines on receiving USFDA approval for ELEPSIA XR extended-release tablets  Arihant Capital3 weeks ago
Business Standard

Sun Pharma Advanced Research zooms 60% in one week

The stock rallied 13% to Rs 316, extending its past four day's over 40% rally on BSE on back of heavy volumes. SI Reporter | Mumbai January 23, 2015 Last Updated at 10:30 IST Shares of Sun Pharma Advanced Research Company (SPARC) have rallied 13% to Rs 316, ...
 Business Standard2 months ago
India Infoline

Sun Pharma Advanced Research stock hits 20% upper circuit

The stock has hit a high of Rs334 and a low of Rs277.
 India Infoline2 months ago Sun Pharma Advanced stock zooms 18%  India Infoline2 months ago SPARC stock ends 7% lower  India Infoline2 weeks ago SPARC stock hits 10% upper circuit after FDA approval  India Infoline3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharma advanced research
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less